GlaxoSmithKline sales and marketing update

GlaxoSmithKline priced gene therapy Strimvelis ( GSK2696273) at EUR594,000 ($663,679). In May, the European Commission approved Strimvelis to treat severe combined immunodeficiency due to adenosine d...